about
Structural and immunological analysis of circumsporozoite protein peptides: a further step in the identification of potential components of a minimal subunit-based, chemically synthesised antimalarial vaccine3D structure determination of STARP peptides implicated in P. falciparum invasion of hepatic cellsBinding activity, structure, and immunogenicity of synthetic peptides derived from Plasmodium falciparum CelTOS and TRSP proteinsPlasmodium falciparum rhoptry neck protein 5 peptides bind to human red blood cells and inhibit parasite invasionComputational prediction and experimental assessment of secreted/surface proteins from Mycobacterium tuberculosis H37RvCharacterising Mycobacterium tuberculosis Rv1510c protein and determining its sequences that specifically bind to two target cell linesMycobacterium tuberculosis Rv2536 protein implicated in specific binding to human cell linesIMPIPS: the immune protection-inducing protein structure concept in the search for steric-electron and topochemical principles for complete fully-protective chemically synthesised vaccine developmentP. falciparum: merozoite surface protein-8 peptides bind specifically to human erythrocytes.MSP-1 malaria pseudopeptide analogs: biological and immunological significance and three-dimensional structure.Elongating modified conserved peptides eliminates their immunogenicity and protective efficacy against P. falciparum malaria.Synthetic vaccine update: applying lessons learned from recent SPf66 malarial vaccine physicochemical, structural and immunological characterization.Mycobacterium tuberculosis Rv0679c protein sequences involved in host-cell infection: potential TB vaccine candidate antigen.Specific interaction between Mycobacterium tuberculosis lipoprotein-derived peptides and target cells inhibits mycobacterial entry in vitro.Using the PfEMP1 head structure binding motif to deal a blow at severe malaria.Functional, immunological and three-dimensional analysis of chemically synthesised sporozoite peptides as components of a fully-effective antimalarial vaccine.Functional, biochemical and 3D studies of Mycobacterium tuberculosis protein peptides for an effective anti-tuberculosis vaccine.Peptides derived from Mycobacterium tuberculosis Rv2301 protein are involved in invasion to human epithelial cells and macrophages.α-Helix peptides designed from EBV-gH protein display higher antigenicity and induction of monocyte apoptosis than the native peptide.Identification of peptides with high red blood cell and hepatocyte binding activity in the Plasmodium falciparum multi-stage invasion proteins: PfSPATR and MCP-1.Characterizing the Mycobacterium tuberculosis Rv2707 protein and determining its sequences which specifically bind to two human cell lines.Identification and characterization of the Plasmodium vivax thrombospondin-related apical merozoite protein.Characterization of Plasmodium falciparum integral membrane protein Pf25-IMP and identification of its red blood cell binding sequences inhibiting merozoite invasion in vitro.Monosaccharides modulate HCV E2 protein-derived peptide biological properties.A Maurer's cleft-associated Plasmodium falciparum membrane-associated histidine-rich protein peptide specifically interacts with the erythrocyte membrane.Conserved regions from Plasmodium falciparum MSP11 specifically interact with host cells and have a potential role during merozoite invasion of red blood cells.Conserved regions of the Plasmodium falciparum rhoptry-associated protein 3 mediate specific host-pathogen interactions during invasion of red blood cells.Characterisation of the Plasmodium vivax Pv38 antigen.Decreasing the configurational entropy and the hydrophobicity of EBV-derived peptide 11389 increased its antigenicity, immunogenicity and its ability of inducing IL-6.Induction and displacement of an helix in the 6725 SERA peptide analogue confers protection against P. falciparum malaria.Protecting capacity against malaria of chemically defined tetramer forms based on the Plasmodium falciparum apical sushi protein as potential vaccine components.Orientating peptide residues and increasing the distance between pockets to enable fitting into MHC-TCR complex determine protection against malaria.Splenectomised and spleen intact Aotus monkeys' immune response to Plasmodium vivax MSP-1 protein fragments and their high activity binding peptides.Structural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteins.Serine repeat antigen peptides which bind specifically to red blood cells.The Plasmodium vivax Pv41 surface protein: identification and characterization.Sequences of the Plasmodium falciparum cytoadherence-linked asexual protein 9 implicated in malaria parasite invasion to erythrocytes.Atomic evidence that modification of H-bonds established with amino acids critical for host-cell binding induces sterile immunity against malaria.Evaluation of the antigenicity of universal epitopes from PvDBPII in individuals exposed to Plasmodium vivax malaria.Identification of conserved erythrocyte binding regions in members of the Plasmodium falciparum Cys6 lipid raft-associated protein family.
P50
Q27652547-B3B405AC-8253-4BF1-81E7-8548131BDCA5Q27662791-142664E6-0D11-4280-B3FC-D8B5F7ADF910Q27674543-5D3CCE6D-1777-4F13-825A-87307209C356Q27973874-EA1769DE-FFD8-4261-B344-BC7F9644004AQ28474670-21E9826C-97F1-459D-9287-2A42336F35BAQ28487029-E48D364C-590C-40C4-94CD-7E34F2EAF5DAQ28487438-D30E8C6F-5CEC-4ECE-9527-1BD8917CE4DAQ30373743-522C52F5-E4F6-48B6-99B4-7CEE5B3C7AC3Q30743558-5F83F3D8-2CE5-4CDA-B7E8-B7CBE3A3BA18Q31137274-E6CB650B-C50F-4993-A592-545D3B27E4B3Q33214973-E9DB1A09-2584-414F-9133-8B2388813DAAQ33280848-AEB5AD91-9E82-4797-8C21-A332B25A6312Q33553900-7D067E58-3BF0-4A7A-9E6D-62B56B0E49B0Q34517241-8930A6D0-1E50-4084-A81C-ED47CC203B27Q35091763-F71F84AA-B921-41B7-8DB8-535D63EC9FCEQ37949675-4CB2AAC7-A5B2-48B8-B07A-723F2E34F37BQ38085081-940D8895-65B9-49BD-916B-BA776960BA6DQ39540019-F954BB8A-D910-42CC-B84C-C2494922D116Q39703319-7EF5B08C-7B81-4D57-8AD8-DBEFFDF71330Q39933146-0508E861-48B5-4921-8608-782579BCD3B7Q40032484-948B326A-978E-4AB9-B2B1-20D8B3F1FEEAQ41916222-FD6AD2FC-FC24-4D53-9209-1F3F36989C0BQ42417080-F9131CEE-6FFA-45CC-BA3E-4344F1176764Q43036066-807A7FDF-8795-4DB6-B2B2-28B9A41E1CC9Q43522146-7835BB2B-4ECE-44BE-B165-EF5934BAE517Q43570250-74714F6D-3B3A-440C-A6D7-ACBBC08F4E91Q44308262-804B40A1-E8E9-4C8B-836A-65F15DD0B2E1Q44423139-E02D1C5C-C8D1-439D-9587-053C39E6E5E2Q44587121-7F69B92B-CA6E-45C6-B585-3349721F76BDQ44788262-E63D940B-81C6-45B7-AD8F-F16B00A612ACQ45167684-0F842EFC-9D19-4490-A9D8-8782ADB87655Q47445161-2F034736-7BFD-4E67-B457-954AFEB53965Q47610245-7E1B5475-BD95-44C0-9836-5F4464AB1BA9Q47861339-A54E8348-5E24-4000-B768-B4A8903511A4Q47867845-48313819-C908-49B6-BBE8-3CAD8E126556Q47886755-91DC8DAD-52DB-4363-8FBD-C208291CB2E0Q47925251-04DD7AF3-12C3-4CDC-ACCE-72D7A9CC9A49Q47929333-11EB0B79-DCFB-4495-9883-07318F5C42CEQ47953060-0CF939BB-8046-4169-AB41-0D21FF98B854Q47954906-DDE6459A-22AE-4DC1-B4D6-3FAD2F960E41
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Magnolia Vanegas
@ast
Magnolia Vanegas
@en
Magnolia Vanegas
@nl
Magnolia Vanegas
@sl
Magnolia Vanegas
@es
type
label
Magnolia Vanegas
@ast
Magnolia Vanegas
@en
Magnolia Vanegas
@nl
Magnolia Vanegas
@sl
Magnolia Vanegas
@es
prefLabel
Magnolia Vanegas
@ast
Magnolia Vanegas
@en
Magnolia Vanegas
@nl
Magnolia Vanegas
@sl
Magnolia Vanegas
@es
P1053
I-7968-2016
P106
P1153
6601944562
P21
P31
P3829
P496
0000-0001-7722-4115